NCT01898312View on ClinicalTrials.gov

BRCA1/2 and Effect of Mifepristone on the Breast

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2021

Study Completion Date

January 31, 2022

Conditions
Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
Interventions
DRUG

Mifepristone

Randomised controlled trial of Mifepristone and placebo comparator Triobe

Trial Locations (1)

17176

Department of Woman and Child Health Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT01898312 - BRCA1/2 and Effect of Mifepristone on the Breast | Biotech Hunter | Biotech Hunter